meclofenamic acid has been researched along with nimesulide in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bell, RL; Hulkower, KI; Otis, ER; Wernimont, AK | 1 |
| González, JD; Llinás, MT; Rivera, J; Rodríguez, F; Salazar, FJ | 1 |
| Llinás, MT; Moreno, C; Rodríguez, F; Salazar, FJ | 1 |
| Mitchell, KD; Mouton, CR; Mullins, JJ; Opay, AL | 1 |
| Llinás, MT; López, R; Salazar, E; Salazar, FJ | 1 |
1 review(s) available for meclofenamic acid and nimesulide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 other study(ies) available for meclofenamic acid and nimesulide
| Article | Year |
|---|---|
Stimulus dependence of non-steroidal antiinflammatory drug potency in a cellular assay of prostaglandin H synthase-2.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Cyclooxygenase Inhibitors; Dexamethasone; Dinoprostone; Drug Interactions; Humans; Ibuprofen; Indans; Indomethacin; Interleukin-1; Meclofenamic Acid; Nitrobenzenes; Okadaic Acid; Prostaglandin-Endoperoxide Synthases; RNA, Messenger; Sulfonamides; Tumor Necrosis Factor-alpha | 1997 |
Renal changes induced by a cyclooxygenase-2 inhibitor during normal and low sodium intake.
Topics: Animals; Arachidonic Acid; Blood Pressure; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Dogs; Female; Glomerular Filtration Rate; Hemodynamics; Isoenzymes; Kidney; Lithium; Male; Meclofenamic Acid; Platelet Aggregation; Platelet Count; Prostaglandin-Endoperoxide Synthases; Renal Circulation; Sodium, Dietary; Sulfonamides; Urodynamics | 2000 |
Role of cyclooxygenase-2-derived metabolites and nitric oxide in regulating renal function.
Topics: Animals; Blood Flow Velocity; Blood Pressure; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dogs; Enzyme Inhibitors; Female; Glomerular Filtration Rate; Infusions, Intravenous; Isoenzymes; Kidney; Male; Meclofenamic Acid; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Sulfonamides; Vascular Resistance | 2000 |
Cyclooxygenase-2 inhibition normalizes arterial blood pressure in CYP1A1-REN2 transgenic rats with inducible ANG II-dependent malignant hypertension.
Topics: Angiotensin II; Animals; Animals, Genetically Modified; Blood Pressure; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cytochrome P-450 CYP1A1; Glomerular Filtration Rate; Hypertension, Malignant; Male; Meclofenamic Acid; Rats; Sulfonamides; Vascular Resistance | 2006 |
Renal Effects of Cyclooxygenase Inhibition When Nitric Oxide Synthesis Is Reduced and Angiotensin II Levels Are Enhanced.
Topics: Angiotensin II; Animals; Blood Pressure; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dogs; Female; Glomerular Filtration Rate; Infusions, Intravenous; Male; Meclofenamic Acid; Models, Animal; Natriuresis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Renal Artery; Sulfonamides; Vasoconstriction | 2015 |